Target intelligence / Profile preview

Reverse Transcriptase (HIV) (RT)

Target
RT
Molecular classification
Enzyme, Polymerase, Reverse Transcriptase
01

Overview

Reverse transcriptase (RT) is a viral enzyme essential for the replication of HIV. It catalyzes the conversion of the single-stranded RNA genome of HIV into double-stranded DNA, a process known as reverse transcription. This enzyme is a heterodimer composed of p66 and p51 subunits and possesses RNA-dependent DNA polymerase, Ribonuclease H (RNase H), and DNA-dependent DNA polymerase activities. Translocation, a key step in the reverse transcription process, involves the movement of RT along the nucleic acid substrate during nucleotide incorporation. RT is a major target for antiretroviral therapy, with drugs like NRTIs, NNRTIs, and NRTTIs designed to inhibit its function. Drug resistance is a significant concern due to the emergence of mutations in RT.

Other names
HIV-1 reverse transcriptaseReverse transcriptaseRT
02

Mechanism of action

Inhibition of reverse transcriptase activity, leading to chain termination or conformational changes that disrupt enzyme function.

03

Biological functions

Reverse transcriptionDNA synthesisRNA degradation (RNase H activity)
04

Disease associations

InfectionHIV infectionAIDS
05

Safety considerations

Drug resistance due to mutations in RTSide effects associated with antiretroviral drugs
06

Interacting drugs

NRTIs

3 more in the full profile.

Beyond the preview

Go deeper on Reverse Transcriptase (HIV) (RT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reverse Transcriptase (HIV) (RT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call